IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT ID: NCT05959122
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-05-20
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
HYPOTHESES:
There is a relation between IDA and pinch strength and hand dexterity in preschool children.
RESEARCH QUESTION:
Is there a relation between IDA and pinch strength and hand dexterity in preschool children?
The purpose of the current study is to find the relation between IDA and:
1. Pinch grip strength (tripod and tip to tip grip strength).
2. Hand dexterity in preschool children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iron Deficiency Anemia in Childern With Liver Cirrhosis
NCT03482076
Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction
NCT04343170
Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women
NCT03212781
Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores
NCT06871917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Fully automated blood cell counter. A complete blood count (CBC) is one of the most commonly and routinely done laboratory tests It will be obtained through the use of fully automated blood cell counter (sysmex-Xs 800i).
2. Beckman coulter-AU 480- blood chemistry auto-analyzer. It is the ideal primary chemistry analyzer for measurement of the amount of serum iron in the blood. ii. Instrumentations for assessment:
Updated 23/11/12
4
1. Baseline mechanical Pinch gauge (0-60 lb.) used to measure tripod pinch strength of dominance and non-dominance hands for all participated children.
2. Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) The Bruininks-Oseretsky Test of Motor Proficiency is a standardized, norm-referenced measure
Inclusion Criteria:
1. Their age will be ranged from 5-6 years
2. The fifty anemic children will have microcytic hypochromic anemia: their Hb \< 11.5 g/L (Hb from 11.0-11.4 is mild anemia and in moderate anemia Hb is from 8.0-10.9 (WHO, 2011). The serum iron is below 60 mcg/dL (Elngar et al., 2021). The Ferritin level
\<12 µg/L for children in absence of infection (WHO, 2017). ( Appendix I).
3. They will be right handed.
4. They had no history of previous hand injuries, surgeries or other functional hand limitation.
5. All children will able to follow instructions and understand commands given during test procedures.
6. Their body mass index (BMI) will be ranged from 15.2 to 15.5 kg/m2 (WHO, 2007). (Appendix II).
B. Exclusion Criteria:
Children will exclude if they have:
1. Congenital or acquired deformity in the joints of upper limb.
2. Unhealed fracture in upper limb bones.
3. Systematic disease that cause anemia such as renal or hepatic failure or a history of bone disease.
4. Blood transfusion within 3 months before measuring the hematological indices.
5. Documented trauma in the previous 12 months in the muscle fibers, or those taking medication that affecting strength.
6. Children begin with musculoskeletal problems or neurological disorders that affected their upper extremities
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
group (A) thirty-six non-anemic children
CBC serum iron serum ferritin
1. Fully automated blood cell counter (sysmex-Xs 800i) and AU 480-Chemistry auto-analyzer (Beckman Coulter Diagnostics-USA) was used for measurement of hemoglobin and serum iron levels
2. Chemiluminescence assay using an Abbott i2000SR analyser was used to measured serum ferritin
group B
group (B) twenty five children with mild IDA
CBC serum iron serum ferritin
1. Fully automated blood cell counter (sysmex-Xs 800i) and AU 480-Chemistry auto-analyzer (Beckman Coulter Diagnostics-USA) was used for measurement of hemoglobin and serum iron levels
2. Chemiluminescence assay using an Abbott i2000SR analyser was used to measured serum ferritin
Group C
group (C) 26 children with moderate
CBC serum iron serum ferritin
1. Fully automated blood cell counter (sysmex-Xs 800i) and AU 480-Chemistry auto-analyzer (Beckman Coulter Diagnostics-USA) was used for measurement of hemoglobin and serum iron levels
2. Chemiluminescence assay using an Abbott i2000SR analyser was used to measured serum ferritin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBC serum iron serum ferritin
1. Fully automated blood cell counter (sysmex-Xs 800i) and AU 480-Chemistry auto-analyzer (Beckman Coulter Diagnostics-USA) was used for measurement of hemoglobin and serum iron levels
2. Chemiluminescence assay using an Abbott i2000SR analyser was used to measured serum ferritin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The fifty anemic children will have microcytic hypochromic anemia: their Hb \< 11.5 g/L (Hb from 11.0-11.4 is mild anemia and in moderate anemia Hb is from 8.0-10.9 (WHO, 2011). The serum iron is below 60 mcg/dL (Elngar et al., 2021). The Ferritin level
\<12 µg/L for children in absence of infection (WHO, 2017). ( Appendix I).
3. They will be right handed.
4. They had no history of previous hand injuries, surgeries or other functional hand limitation.
5. All children will able to follow instructions and understand commands given during test procedures.
6. Their body mass index (BMI) will be ranged from 15.2 to 15.5 kg/m2 (WHO, 2007). (Appendix II).
Exclusion Criteria
1. Congenital or acquired deformity in the joints of upper limb.
2. Unhealed fracture in upper limb bones.
3. Systematic disease that cause anemia such as renal or hepatic failure or a history of bone disease.
4. Blood transfusion within 3 months before measuring the hematological indices.
5. Documented trauma in the previous 12 months in the muscle fibers, or those taking medication that affecting strength.
6. Children begin with musculoskeletal problems or neurological disorders that affected their upper extremities
7. Children who practice in any regular sport activities involving the upper extremities.8)
5 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Essam ELDIN ABDALLAH AMER
Physical therapist at Zagazig General Hospital, El Sharkia, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the Outpatient Clinic of Pediatrics, Zagazig University Hospitals.
Zagazig, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No: P.T.REC/012/001850
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.